소아의 지속성 혈액여과법

Abstract

Continuous arteriovenous hemofiltration (CAVH) which was described by Kramer in 1977 provides an alternative method for the treatment of acute renal failure. Seven children with acute renal failure and refractory edema, were treated with continuous hemofiltration. Five of the seven patients had acute renal failure with refractory edema and the remainder had acute renal failure with multiple organ failure. The duration of treatment ranged from 12 to 126 hours, with a mean of 57±65 hours. The mean ultrafiltration rate was 7.7±4.4 ml/min and the mean weight loss during treatment was 4.7±2.8 Kg. Changes in blood chemistry before and after treatment were not significantly different except for BUN (92±16 vs 66±:I8mg/dl，p<0.05). We observed initial clinical improvement in all cases but two patients died from pneumonia and sepsis, developed Jater. There was one episode of Wood line dotting and one case of hypotension during hemofiltration. We concluded that continuous hemofiltration in children is a safe and effective method in the treatment of acute renal failure with intractable edema and multiple organ failure.